|1.||Stenman, Ulf-Håkan: 5 articles (05/2008 - 10/2002)|
|2.||Nowak-Markwitz, Ewa: 4 articles (01/2013 - 01/2004)|
|3.||Jankowska, Anna: 4 articles (01/2013 - 01/2004)|
|4.||Alfthan, Henrik: 4 articles (05/2008 - 10/2002)|
|5.||Iles, Ray K: 3 articles (09/2013 - 12/2003)|
|6.||Butler, Stephen A: 3 articles (09/2013 - 12/2003)|
|7.||Szczerba, Anna: 3 articles (01/2011 - 01/2004)|
|8.||Xiang, Yang: 3 articles (06/2009 - 01/2007)|
|9.||Haglund, Caj: 3 articles (09/2004 - 10/2002)|
|10.||Louhimo, Johanna: 3 articles (09/2004 - 10/2002)|
12/01/1987 - "The retroperitoneal metastatic tumor disappeared and HCG-beta was normalized and complete remission achieved, but cerebellar symptoms still remain 14 months after remission. "
08/01/1981 - "The urinary hCG assay was considerably more effective in detecting increased hCG production, and, hence, persistent tumor burden, than the commonly used serum hCG beta subunit radioimmunoassay. "
06/01/1997 - "This study thus presents a potential approach to inhibiting growth of human tumor cells that produce and secrete the free hCG beta protein."
03/01/1996 - "As an in vivo study, distribution of IR-hCG beta was analyzed in tumor tissues, sera, and urine of the nude mice and the nude rat transplanted with KoTCC-1 cell line. "
09/01/1995 - "However, tumor progression was characterized by different patterns of transcription of the hCG beta genes; the beta 7 gene was the only gene transcribed in normal urothelia and Ta tumors included in this study, whereas in addition to beta 7, genes beta 5, 8, and 3 were transcribed in T1 to T4 tumors. "
12/01/1989 - "[Studies on the transcriptional regulatory elements of the hCG beta gene cluster using a choriocarcinoma cell line which expresses hCG beta eutopically]."
09/01/2006 - "Although the number of GPC3-positive cells was smaller in STGC components and choriocarcinoma, there was no diffusion artifact in GPC3 immunostaining, as was frequently encountered in hCG-beta staining. "
12/01/2001 - "Immunohistochemistry showed localization of hCG beta cf immunoreactivity to the syncytiotrophoblasts and scattered cells in the stroma of mole tissue, and to syncytiotrophoblastic cells in choriocarcinoma. "
03/01/2000 - "The cells were positive for the alpha-hCG, beta-hCG subunits, hPL and Ki-67, consistent with intraplacental choriocarcinoma. "
04/01/1998 - "Identification of choriocarcinoma by the hCG beta-to-hCG proportion in patients with delayed diagnosis caused by contraceptive use."
03/15/1992 - "In accord with the immunological data, gel chromatographical studies of malignant ascites revealed the abundance of free hCG-beta subunit rather than that of holo-hCG. "
01/01/1996 - "In conclusion, hCG-beta is frequently elevated in malignancy-related ascites and seems to be as useful a parameter as total protein for the differentiation of malignancy-related from nonmalignant ascites."
03/15/1992 - "In conclusion, hCG-beta immunoreactivity is frequently elevated in malignancy-related ascites and appears to be related to the presence of free beta subunit of hCG rather than that of the intact hCG molecule. "
03/15/1992 - "For comparison, in ascites, hCG (+hCG-beta) concentrations were frequently higher than in the corresponding serum samples and exceeded 10 IU/liter in 0 of 20 cirrhotic samples and in 16 of 20 malignant samples. "
11/01/1995 - "In malignant ascites (n = 15) and tumour cyst fluids (n = 11) of patients with ovarian cancer, hCG/hCG beta concentrations were significantly higher than in the corresponding serum samples and benign ascitic samples. "
|4.||Neoplasm Metastasis (Metastasis)
06/01/2009 - "Univariate analysis found that predictors of response were age (p=0.022), antecedent pregnancy (p=0.022), site of metastasis (p=0.026), and preoperative serum human chorionic gonadotropin-beta subunit (beta-hCG) level (p=0.027). "
07/01/1986 - "Abnormal pre-treatment level of hCG-beta did not always indicate poor clinical courses, since in patients under stage III A pre-treatment level of hCG-beta did not correlate to either treatment results or clinical courses, even in patients with bulky metastasis such as stage IIIB1, B2 or C their treatment results and clinical courses seemed to be primarily determined by the size and extent of metastasis. "
02/01/2000 - "After two courses of PEB chemotherapy, the serum hCG-beta level fell to within the normal range and all pulmonary metastases disappeared."
02/01/2000 - "Although the serum hCG-beta level fell to 0.1 ng/ml, after two courses of MVC chemotherapy, bilateral pulmonary metastases appeared in the chest X-ray with increasing hCG-beta levels. "
07/01/2000 - "It is important to evaluate the spread of tumor cells for the choice of therapy and the monitoring of HCG beta (plasma:CSF ratio) was considered to be one of the useful methods to detect the presence of central nerve system metastases from HCG-producing tumor."
05/01/1992 - "The introduction of sensitive assays for the beta subunit of hCG (beta-hCG) and improved ultrasound technology for diagnosis and monitoring of ectopic pregnancy have changed the clinical approach to the management of ectopic pregnancy. "
06/01/2006 - "To assess the value of monitoring serum human chorionic gonadotropin beta-subunit (beta-HCG) level changes in early diagnosis of ectopic pregnancy. "
06/01/2006 - "[Dynamic monitoring of serum human chorionic gonadotropin beta-subunit levels for early diagnosis of ectopic pregnancy]."
01/01/1982 - "The results show the superiority of the HCG beta-subunit RIA compared to the conventional diagnostic methods in the diagnosis of ectopic pregnancy."
01/01/1982 - "Diagnostic value of a rapid HCG-beta-subunit radioimmunoassay in cases of suspected ectopic pregnancies."
|4.||Chorionic Gonadotropin (Human Chorionic Gonadotropin)
|5.||Human beta Subunit Chorionic Gonadotropin
|6.||urinary gonadotropin fragment
|10.||alpha Subunit Glycoprotein Hormones
|1.||Drug Therapy (Chemotherapy)
|3.||Induced Abortion (Induced Abortions)